During the past decade, Cancer Hospital Chinese Academy of Medical Sciences，Shenzhen center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Hospital Chinese Academy of Medical Sciences，Shenzhen center" #1 sponsor was "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 2 trials, followed by "Taizhou Hanzhong biomedical co. LTD" with 2 trials sponsored, "Fudan University" with 1 trials sponsored, "Herui Yao" with 1 trials sponsored and "Jacobio Pharmaceuticals Co., Ltd." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Hospital Chinese Academy of Medical Sciences，Shenzhen center" #1 collaborator was "GeneCast Biotechnology Co., Ltd." with 1 trials as a collaborator and "Jiangsu Hansoh Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Hospital Chinese Academy of Medical Sciences，Shenzhen center" are "Advanced Solid Tumor" (2 trials), "Advanced Cancer" (1 trials), "Breast Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Cancer Hospital Chinese Academy of Medical Sciences，Shenzhen center" in a lesser frequency.

Most popular intervention types in "Cancer Hospital Chinese Academy of Medical Sciences，Shenzhen center" are "Drug" (10 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "HX008" (2 trials), "Pemetrexed" (2 trials), "Almonertinib" (1 trials), "Amivantamab" (1 trials) and "Anti-PD-1 Immune Checkpoint Inhibitors" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Hospital Chinese Academy of Medical Sciences，Shenzhen center" are 9 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Cancer Hospital Chinese Academy of Medical Sciences，Shenzhen center". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Cancer Hospital Chinese Academy of Medical Sciences，Shenzhen center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Hospital Chinese Academy of Medical Sciences，Shenzhen center, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".